Cargando…

264 Results of the Surveillance of Tedizolid Activity and Resistance (STAR) Program: In Vitro Susceptibility of Gram-Positive Clinical Isolates Collected in 2013 From the United States

Detalles Bibliográficos
Autores principales:	Bien, Paul, Prokocimer, Philippe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2014
Materias:	IDWeek 2014 Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781408/ http://dx.doi.org/10.1093/ofid/ofu052.130

Ejemplares similares

262 Effect of NSAID/Corticosteroid Use on the Efficacy of Tedizolid in Acute Bacterial Skin and Skin Structure Infections: Pooled Data From the Phase 3 ESTABLISH-1 and ESTABLISH-2 Studies
por: Sandison, Taylor, et al.
Publicado: (2014)

155 Implementation of a national surveillance program for antimicrobial use, Colombia 2012-2013
por: Moreno, Carlos Arturo Alvarez, et al.
Publicado: (2014)

247 Antimicrobial Activity of Ceftolozane/Tazobactam Tested against Gram-negative Bacterial Isolates from Hospitalized Patients with Pneumonia in United States Hospitals (2013)
por: Farrell, David J., et al.
Publicado: (2014)

145 Differences in Antimicrobial Use and Susceptibilities for Gram Negative Organisms between Intensive Care Units and the Emergency Department: Implications for Antimicrobial Stewardship
por: Talledo, Karla, et al.
Publicado: (2014)

904 Multidrug-Resistant Gram-Negative Bacteria (MRGN) in Intensive Care Units - Results from the German National Surveillance System for Nosocomial Infections (KISS)
por: Behnke, Michael, et al.
Publicado: (2014)

1136 Surveillance of Acute Flaccid Paralysis (AFP) in the Republic of Korea during 2012-2013
por: Yoon, Young-Sil, et al.
Publicado: (2014)

250 Ceftazidime-avibactam Activity Tested Against a Large Collection of Enterobacteriaceae Isolates Collected in United States (USA) Hospitals in the 2011-2013 Period, Including Organisms Producing KPC- and CTX-M-variants
por: Castanheira, Mariana, et al.
Publicado: (2014)

1076 Assessment of the Status of Measles Elimination in the United States, 2001-2013
por: Gastanaduy, Paul, et al.
Publicado: (2014)

470 Oritavancin Activity Against Gram-positive Clinical Isolates Responsible for Documented Skin and Skin Structure Infections in USA and European Hospitals (2012-2013)
por: Mendes, Rodrigo E., et al.
Publicado: (2014)

769 Short Duration of Antimicrobial Treatment for Acute Cholangitis with Bacteremia due to Gram-negative Bacilli after the Publication of the Updated Tokyo Guidelines 2013 (TG13)
por: Uno, Shunsuke, et al.
Publicado: (2014)

976 Antiseptic tolerance and antimicrobial susceptibility of nosocomial Staphylococcus aureus at Texas Children's Hospital: 2007-2013
por: Mcneil, Jonathon, et al.
Publicado: (2014)

1712 An Integrated Surveillance for Antimicrobial-Resistance in Salmonella from Clinical and Retail Meat Sources — Pennsylvania, 2009-2013
por: Mikanatha, Nkuchia, et al.
Publicado: (2014)

1454 Antifungal Susceptibility Patterns of a Global Collection of Fungal Isolates and Polysorbate-80 Effect on the Susceptibility of the Antifungal Classes
por: Castanheira, Mariana, et al.
Publicado: (2014)

802 The Cost of a Measles Outbreak in 2013, New York City, United States
por: Khawja, Amina, et al.
Publicado: (2014)

410 Tracking Linezolid Antimicrobial Activity and Resistance in North America: Results from LEADER 2013 Program
por: Flamm, Robert K., et al.
Publicado: (2014)

1065 Surveillance and Vaccine Effectiveness Results from the Department of Defense (DoD) Global, Laboratory-Based, Influenza Surveillance Program
por: Thervil, Jeffrey, et al.
Publicado: (2014)

77 Continued Decline in Invasive Pneumococcal Infections in Children Among 8 Children's Hospitals in the United States 2011 to 2013
por: Kaplan, Sheldon L., et al.
Publicado: (2014)

712 Gram-negative associated Ventricular Assist Device infections
por: Patel, Ami, et al.
Publicado: (2014)

1690 Opportunities for Improved Detection and Treatment of Latent Tuberculosis Infection Among Veterans — Western United States, January 2010–July 2013
por: Perti, Tara, et al.
Publicado: (2014)

413 In Vitro Activity of Tigecycline against Commonly-Isolated Pathogens of Skin and Skin Structure Infections in the United States – TEST 2011-2013
por: Hackel, Meredith, et al.
Publicado: (2014)

948 Impact of active surveillance program to control VRE in a university hospital with low endemic rates
por: Cardoso, Luis Gustavo De Oliveira, et al.
Publicado: (2014)

1004 Technical and Logistical Issues in Incorporating Statistical Process Control into Healthcare-Associated Infection Surveillance Programs
por: Baker, Arthur W., et al.
Publicado: (2014)

714 Gram Negative Bacteremia: Are Shorter Courses of Antimicrobial Therapy Feasible?
por: Swamy, Siddharth, et al.
Publicado: (2014)

475 Telavancin (TLV) In vitro Activity Tested Against a USA Collection of Methicillin-resistant Staphylococcus aureus (MRSA), Including a Multidrug-resistant (MDR) Subset (2011-2013)
por: Mendes, Rodrigo E., et al.
Publicado: (2014)

1734 Cyclosporiasis 2013: Collaborative Outbreak Investigations
por: Gensheimer, Kathleen, et al.
Publicado: (2014)

729 Activity of Ceftaroline and Comparator Agents Tested against Staphylococcus aureus from Patients with Bacteremia in United States (USA) Medical Centers (2009-2013)
por: Sader, Helio S., et al.
Publicado: (2014)

715 Impact of Fluoroquinolone Resistance on Community-Onset Gram-Negative Bloodstream Infections
por: Brigmon, Matthew, et al.
Publicado: (2014)

489 Accuracy of Clinicians' Empiric Treatment Choices for Resistant Gram-Negative Uropathogens
por: Linsenmeyer, Katherine, et al.
Publicado: (2014)

456 Infectious Myositis Secondary to Multidrug-Resistant Gram Negative Rods in Cancer Patients
por: Mori, Nobuyoshi, et al.
Publicado: (2014)

357 Epidemiology of Carbapenem-Resistant Gram-Negative Bacilli in Georgia, Minnesota, and Oregon – 2012
por: Guh, Alice, et al.
Publicado: (2014)

252 S-649266, a Novel Siderophore Cephalosporin: In vitro activity against Gram-negative bacteria
por: Tsuji, Masakatsu, et al.
Publicado: (2014)

832 Predictive Factors of Spontaneous Bacterial Peritonitis Caused by Gram-positive Bacteria in Cirrhotic Patients
por: Kim, Jung Ho, et al.
Publicado: (2014)

309 Clinical, Psycho-social and Cost Impacts of Performing Active Surveillance to Discontinue MRSA Contact Isolation for Patients Admitted to Medical-surgical Units
por: Power, Michelle, et al.
Publicado: (2014)

490 High Dose Tigecycline for the Treatment of Multi-Drug Resistant Gram Negative Urinary Tract Infections
por: Sam, Sharon, et al.
Publicado: (2014)

450 Multidrug Resistant Gram Negative Bacteria in a Cohort of Hematopoietic Stem Cell Transplant Recipients
por: Larue, Richard, et al.
Publicado: (2014)

169 Rapid Testing using Verigene® Microarray in Combination with Antimicrobial Stewardship Intervention in Gram-negative Bacteremia
por: Bork, Jacqueline T., et al.
Publicado: (2014)

482 Intrathecal Colistin Therapy to Treat Multidrug Resistant Gram Negative Central Nervous System Infection
por: Mukherjee, Dip Narayan
Publicado: (2014)

Pharmacokinetics of Tedizolid and Pseudoephedrine Administered Alone or in Combination in Healthy Volunteers
por: Flanagan, Shawn, et al.
Publicado: (2018)

1001 Success of Perinatal Hepatitis C Testing: Philadelphia, 2011 - 2013
por: Kuncio, Danica, et al.
Publicado: (2014)

1741 Emergence of Shigellosis in Males ≥13 Years — Philadelphia, 2008–2013
por: Finn, Lauren, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mpr993v3887mn5jm4rrecbsm6h